Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Shan Lu

Shan Lu

University of Massachusetts Medical School USA

Igor S Lukashevich

Igor S Lukashevich

University of Louisville USA

Kei Amemiya

Kei Amemiya

US Army Medical Research Institute of Infectious Diseases USA

Magdalena Tary-Lehmann

Magdalena Tary-Lehmann

Cellular Technology Limited USA

Weiping Zhang

Weiping Zhang

Kansas State University USA

Ana Gervassi

Ana Gervassi

Center for Infectious Disease Research USA

Hans-Christian Stahl

Hans-Christian Stahl

Universität Heidelberg Germany

Pascal Breton

Pascal Breton

VitamFero France

Euro Vaccines 2018

About Conference

Conference Series Ltd looks forward to welcome all the participants across the world to attend "30th Euro Global Summit and Expo on Vaccines & Vaccination" during June 14-16, 2018 in Barcelona, Spain. The conference highlights the theme “Roadmap on the future of Vaccines Research”.

Euro Vaccines 2018 conference features highly enlightening and interactive sessions to encourage the exchange of ideas across a wide range of disciplines in the field of vaccination and therapeutics. The conference includes explicit keynote talks from distinguished scientists, plenary sessions, Poster competition, Young Researcher sessions, Symposiums, Workshop and Exhibitions. There will be opportunities for those chosen to present at the meeting to publish a manuscript based on their presentation in the Journal of Vaccines & Vaccination or its sister publication, Journal of Clinical & Cellular Immunology and Immunome Research. Conference Series organizes 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

Euro Vaccines 2018 is aimed to give an opportunity that with scholars from around the world focused on learning about Vaccines & Immunology and its advances; this is the best opportunity to reach the largest assemblage of participants from the Vaccines & Immunology community. It provide an explicit platform for presentations, distribute information, meet with current and potential scientists, make a splash with new vaccines developments, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Vaccines & Immunology are hallmarks of this conference.

Target Audience:

  • Researchers & Scientists related to Vaccine R&D
  • Deans and Professors
  • Directors, CEOs, Presidents and Vice Presidents
  • University Faculty
  • Medical Schools/Colleges
  • Nursing Schools/Colleges
  • Associations and Societies related to Vaccine R&D
  • Vaccination Programme Organising Government and Non-government Organisations
  • Business Entrepreneurs
  • Medical Devices Manufacturing Companies
  • Vaccine Manufacturing Companies
  • Vaccine Developers and Investigators

Sessions/Tracks

Track 1: Human Vaccines - Infectious & Non Infectious Diseases

vaccine is an inactivated form of bacteria or virus that is injected into the body to simulate an actual infection. Because the injected microorganisms are 'dead,' they don't cause a person to become sick. Instead, vaccines stimulate an immune response by the body that will fight off that type of illness. It covers infectious disease targets and non-infectious disease targets. To generate vaccine-mediated protection is a complex challenge. Currently available vaccines have largely been developed empirically, with little or no understanding on how they activate the immune system. Their early protective efficacy is primarily conferred by the induction of antigen-specific antibodies. However, there is more to antibody-mediated protection than the peak of vaccine-induced antibody titers.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

5th International congress on Infectious Diseases, March 1-2, 2018 Berlin, Germany; 4th World Congress on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; International Conference on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 13th World Congress on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 6th Euro-Global Conference on Infectious Diseases, September 7-9, 2017 Paris, France; 3rd International Conference on Influenza and Zoonotic Diseases, August 21-22, 2017 Birmingham, UK; 18th International Congress on Infectious Diseases, March 1-4, 2018 Buenos, Argentina; The European Congress of Clinical Microbiology and Infectious Diseases, April 21-24, 2018 Madrid, Spain; ICID 2018; 20th International Conference on Infectious Diseases, January 29-30, 2018 Sydney, Australia; Twelfth Annual Congress on Infectious Diseases Update for Primary Care and Hospital Medicine, September 14-15, 2017 Baltimore, USA; 30th Annual Conference on Infectious Diseases in Children, November 18-19, 2017 New York, USA; Conference on Infectious Diseases: Adult Issues in the Outpatient and Inpatient Settings, April 02-06, 2018 Florida, USA; ID Week 2017 Infectious Diseases Society of America Conference (IDSA), October 4-7, 2017 California, USA; 10th World Congress of the World Society of Pediatric Infectious Diseases (WSPID), December 2-5, 2017 Shenzhen, China

Related Societies:

Europe:

European Society for Paediatric Infectious Diseases; European Union Geriatric Medicine Society; European Federation of Immunological SocietiesEuropean Academy of Allergy and Clinical Immunology

USA:

The Anti-Vaccination Society of AmericaInfectious Diseases Society of AmericaAssociation of Immunization ManagersClinical Immunology Society

Asia and Middle-East:

Japanese Society for ImmunologySingaporean Society for ImmunologyAustralasian Society of Clinical Immunology and Allergy

Track 2: Vaccine Research & Development

Vaccine Development is an activity that focuses on a variety of technological initiatives and applied research, which enhance and promote improved systems and practices for vaccine safety. In the past year, the unprecedented Ebola disease outbreak galvanized research and industry response and as we continue to search for solutions, we must review the lessons learned in order to overcome the current challenges. Vaccines development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. The current system for developing, testing, and regulating vaccines developed during the 20th century as the groups involved standardized their procedures and regulations.

Related Vaccines Conferences Immunology Conferences | World Vaccine Congress

29th International Conference on Vaccines and Immunization, March 19-20, 2018 London, UK; 9th Molecular Immunology & Immunogenetics Congress, March 08-09, 2018 London, UK; 9th European Immunology Conference, June 14-16, 2018 Rome, Italy; 2nd International Conference on Autoimmunity, November 06-07, 2017 Frankfurt, Germany; 11th International Conference on Allergy, Asthma & Clinical Immunology, September 07-08, 2017 Edinburgh, Scotland; 5th International congress on Infectious Diseases, March 1-2, 2018 Berlin, Germany; International Conference on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 4th ESCMID Conference on Vaccines, September 8-10, 2017 Dubrovnik, Croatia; 2017 International Society for Vaccines (ISV) Annual Congress, October 5-7, 2017 Paris, France; Vaccines Research & Development Summit 2017, November 20-22, 2017, Valencia, Spain; 2nd Global Conference on Vaccines Research, March 19-20, 2018 London, UK; World Vaccine Congress Washington 2018, April 3-5, 2018 Washington DC, USA; Global Congress on Vaccines and Vaccination Techniques, April 16-18, 2018, Dubai, UAE; 4th  Global Conference on Virology and Vaccines, April 19-21, 2018 Valencia, Spain; 48th National Immunization Conference, May 15-17, 2018 Atlanta, USA; Vaccines Technology Conference VII, June 17-22, 2018 Quebec, Canada; HIV Research for prevention conference (HIVR4P) October 21-25, 2018 Madrid, Spain

Related Societies:

Europe:

European Academy of Paediatrics; European Malaria Foundation (e-malaria Foundation); European Malaria Vaccine Development (EUROMALVAC); European malaria Vaccine Initiative (EMVI)

USA:

Autism Science Foundation (ASF); Childhood Influenza Immunization Coalition (CIIC); Edward Jenner Vaccine SocietyGlobal Polio Eradication Initiative    

Asia and Middle-East:

Lebanese Society of Allergy and ImmunologyMoldavian Society of Allergology & ImmunologyMoroccan Society of Allergology and Clinical Immunology

Track 3: HIV Vaccines

An AIDS vaccine does not yet exist, but efforts to develop a vaccine against HIV, the virus that causes AIDS, have been underway for many years. An HIV vaccine could be effective in either of two ways. A “preventive” vaccine would stop HIV infection occurring altogether, whereas a “therapeutic” vaccine would not stop infection, but would prevent or delay illness in people who do become infected, and might also reduce the risk of them transmitting the virus to other people. Although a preventive vaccine would be ideal, therapeutic vaccines would also be highly beneficial. The basic idea behind all HIV vaccines is to encourage the human immune system to fight HIV. 

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 29th International Conference on Vaccines and Immunization, March 19-20, 2018 London, UK ; 5th International Conference on HIV/AIDS, STDs and STIs, November 13-14, 2017 Las Vegas, Nevada, USA; 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; 9th European Immunology Conference, June 14-16, 2018 Rome, Italy; 2nd International Conference on Autoimmunity, November 06-07, 2017 Frankfurt, Germany; 11thInternational Conference on Allergy, Asthma & Clinical Immunology, September 07-08, 2017 Edinburgh, Scotland; 22nd International AIDS Conference (AIDS 2018) July 23-27 2018 Amsterdam, Netherlands; CHA 2018; 20thInternational Conference on HIV and AIDS, May 14 - 15, 2018 London, UK; The annual Conference on Retroviruses and Opportunistic Infections (CROI), March 4 -7, 2018 Massachusetts, USA; 12th Annual ACTHIV, April 5 - 7, 2018, Chicago, USA; 20th Bangkok International Symposium on HIV Medicine 2018, January 17 - 19, 2018, Bangkok, Thailand; 2ndInternational Workshop on Healthy Living for HIV Infected Individuals, September 01-02, 2017 Barcelona, Spain; 21stAnnual United States Conference on AIDS (USCA),  September 07-09, 2017 Washington, DC, USA; European Workshop on Healthy Living with HIV, September 15-16, 2017 Barcelona, Spain; 16th European AIDS Conference, October 25-28, 2017 Mila, Italy; Australasian  AIDS Conference 2017, November 06-08, 2017 Canberra,  Australia; ICASA 2017: International Conference on AIDS and STIs in Africa (ICASA), December 04-09, 2017; Côte d’Ivoire, West Africa

Related Societies:

Europe:

British Society for ImmunologyMicrobiology Society, London; Society for Applied MicrobiologyEuropean Society of Clinical Microbiology and Infectious Diseases

USA:

The Federation of Clinical Immunology Societies; The American Association of ImmunologistsAmerican Society for MicrobiologyColombian Allergy, Asthma and Immunology AssociationCanadian Society for Immunology

Asia and Middle-East:

Indian society of Allergy, Asthma and Clinical ImmunologyAustralasian Society of Clinical Immunology and AllergyBangladesh Society of Allergy and Immunology

Track 4: Cancer Vaccines

Immunotherapeutics is treatment that uses your body's own immune system to help fight cancer. Get information about the different types of immunotherapy and the types of cancer they are used to treat. The main types of immunotherapy now being used to treat cancer include:

  1. Cancer vaccines
  2. Monoclonal antibodies
  3. Immune checkpoint inhibitors
  4. Other, non-specific immunotherapies

Some types of immunotherapy are also sometimes called biologic therapy or biotherapy.

In the last few decades immunotherapy has become an important part of treating some types of cancer. Newer types of immune treatments are now being studied, and they’ll impact how we treat cancer in the future.

Immunotherapy includes treatments that work in different ways. Some boost the body’s immune system in a very general way. Others help train the immune system to attack cancer cells specifically. Immunotherapy works better for some types of cancer than for others. It’s used by itself for some of these cancers, but for others it seems to work better when used with other types of treatment.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

28th Euro Congress on Cancer Science & Therapy, August 09-10, 2018 Madrid, Spain; 27th  International Conference on Oncology Research & Cancer Stem Cells, May 10-12, 2018 Frankfurt, Germany; 9th International Conference on Leukemia and Hematologic Oncology, October 05-06,2017 London, UK; 2nd International Congress on Epigenetics & Chromatin, November 06-08, 2017 Frankfurt, Germany; 9th World Biomarkers Congress, December 07-08, 2017 Madrid, Spain; Global Summit on Oncology & Cancer, March 14-16, 2018 Singapore;11th European Breast Cancer Conference (EBCC-11), March 21-23, 2018 Barcelona, Spain; 35th Annual Miami Breast Cancer Conference, March 8-11, 2018 Florida, USA; A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Cancer Treatments Conference, February 1- 3, 2018, Amsterdam, Netherlands; Radiation Break-through: from DNA damage responses to precision cancer therapy Conference, March 12 – 14, 2018 Oxford, UK; Molecular Pathology Approach to Cancer, Amsterdam, Netherlands, 4 - 6 June 2018; 25th Biennial Congress of the European Association for Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; World Cancer Congress, October 1-4 2018 Kuala Lumpur, Malaysia; Conference on Cancer Immunotherapy: Combinations (C5), March 23-27, 2018, Québec, Canada; ESMO 2017 Congress-Integrating science into oncology for a better patient outcome, September 08-12 2017 Madrid, Spain

Related Societies:

Europe:

Albanian Society of Allergology and Clinical ImmunologyAustrian Society of Allergology and ImmunologyBelgian Society of Allergy and Clinical ImmunologyBritish Society of Allergy and Clinical Immunology

USA:

Argentine Association of Allergy and ImmunologyArgentine Society of Allergy and ImmunologyBrazilian Society of Allergy and ImmunologyChilean Society of Allergy and Immunology

 Asia and Middle-East:

Allergy & Immunology Society of Sri LankaAllergy and Clinical Immunology Society of SingaporeAllergy and Immunology Society of Thailand

Track 5: Childhood Vaccines

Vaccination given to children is called children Immunization. It is currently recommended that all children receive vaccination against the infectious diseases unless the child has special circumstances, such as a compromised immune system or neurological disorders. In our mobile society, over a million people each day people travel to and from other countries, where many vaccine-preventable diseases remain relatively common. Without vaccines, epidemics of many preventable diseases could return, resulting in increased - and unnecessary - illness, disability, and death among children.

We have record or near record low levels of vaccine-preventable childhood diseases in the United States, but that does not mean these have disappeared. Many of the viruses and bacteria are still circulating in this country or are only a plane ride away. That’s why it’s important that children, especially infants and young children receive recommended immunizations on time.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

20th International Conference on Neonatology and Perinatology, December 04-06, 2017 Madrid, Spain; 15thInternational Conference on Pediatrics and Pediatric Cardiology, February 19-20, 2018 Paris, France; 20thInternational Conference on Pediatrics Primary Care, September 03-04, 2018 Zurich, Switzerland; 3rd International Conference on Pediatric Surgery, May 07-08, 2018 Frankfurt, Germany; 14th International Conference on Clinical Pediatrics, June 14-16, 2018 Rome, Italy; 4th ESCMID Conference on Vaccines, September 8-10, 2017 Dubrovnik, Croatia; 2017 International Society for Vaccines (ISV) Annual Congress, October 5-7, 2017 Paris, France; Vaccines Research & Development Summit 2017, November 20-22, 2017, Valencia, Spain; 2nd Global Conference on Vaccines Research, March 19-20, 2018 London, UK; World Vaccine Congress Washington 2018, April 3-5, 2018 Washington DC, USA; Global Congress on Vaccines and Vaccination Techniques, April 16-18, 2018, Dubai, UAE; 4th  Global Conference on Virology and Vaccines, April 19-21, 2018 Valencia, Spain; 48th National Immunization Conference, May 15-17, 2018 Atlanta, USA; Vaccines Technology Conference VII, June 17-22, 2018 Quebec, Canada; HIV Research for prevention conference (HIVR4P) October 21-25, 2018 Madrid, Spain

Related Societies:

Europe:

Swiss Society for MicrobiologyFederation of European Microbiological SocietiesInternational Society of VaccinesInternational Union of Immunological Society

USA:

Ecuadorian Society of Allergy, Asthma, and ImmunologyGuatemalan Allergy, Asthma and Clinical Immunology AssociationHonduran Society of Allergy and Clincial Immunology

Asia and Middle-East:

Indonesian Society of Allergy and ImmunologyKorean Academy of Asthma, Allergy and Clinical ImmunologyMalaysian Society of Allergy and Immunology

Track 6: Vaccines safety & Efficacy

Vaccines are the best defense we have against serious, preventable, and sometimes deadly contagious diseases. Vaccines are some of the safest medical products available, but like any other medical product, there may be health risk. Accurate information about the value of vaccines as well as their possible side-effects helps people to make informed decisions about vaccination. The safety of vaccines is carefully monitored, starting early in the product development and continuing for as long as the vaccine is being used. Find out about what is done before and after vaccines are approved for use and what is known about the benefits and safety of specific vaccines. There is a lot of false information about vaccines safety on the Internet. This can be confusing. Discover the answers to common questions and concerns about vaccines.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

6th Euro-Global Conference on Infectious Diseases, September 7-9, 2017 Paris, France; 5th  International congress on Infectious Diseases, March 1-2, 2018 Berlin, Germany; 4th World Congress on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; International Conference on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 13th World Congress on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; 3rd International Conference on Flu and Emerging Infectious Diseases, November 06-07, 2017 Las Vegas, Nevada, USA; 18th International Congress on Infectious Diseases, March 1-4, 2018 Buenos, Argentina; The European Congress of Clinical Microbiology and Infectious Diseases, April 21-24, 2018 Madrid, Spain; ICID 2018 : 20th International Conference on Infectious Diseases, January 29-30, 2018 Sydney, Australia; Twelfth Annual Congress on Infectious Diseases Update for Primary Care and Hospital Medicine, September 14-15, 2017 Baltimore, USA; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 New York, USA; Conference on Infectious Diseases: Adult Issues in the Outpatient and Inpatient Settings, April 02-06, 2018 Florida, USA; ID Week 2017 Infectious Diseases Society of America Conference(IDSA), October 4-7, 2017 California, USA; 10th World Congress of the World Society of Pediatric Infectious Diseases(WSPID), December 2-5, 2017 Shenzhen, China

Related Societies:

Europe:

Croatian Society of Allergology and Clinical Immunology; Czech Society of Allergology and Clinical ImmunologyFinnish Society of Allergology and Clinical ImmunologyFrench Society of Allergology and Clinical Immunology

USA:

Panamanian Association of Allergology and Clinical ImmunologyParaguayan Society of Allergy, Asthma, and ImmunologyPeruvian Society of Allergy and ImmunologyVenezuelan Society of Allergy, Asthma and Immunology

Asia and Middle-East:

Philippine Society of Allergy, Asthma and ImmunologyTaiwan Academy of Pediatric Allergy Asthma ImmunologyVietnam Association of Allergy, Asthma and Clinical Immunology

Track 7: Vaccination for Pregnant Women

Vaccines can help keep you and your growing family healthy. If you are pregnant or planning a pregnancy, the specific vaccinations you need are determined by factors such as your age, lifestyle, medical conditions you may have, such as asthma or diabetes, type and locations of travel, and previous vaccinations. Benefits of vaccinating pregnant women usually outweigh potential risks when the likelihood of disease exposure is high, when infection would pose a risk to the mother or fetus, and when the vaccine is unlikely to cause harm. All women who will be pregnant (any trimester) during the flu season should be offered this vaccine. Talk to your doctor to see if this applies to you. Tetanus/Diphtheria/Pertussis (Tdap): Tdap is recommended during pregnancy, preferably between 27 and 36 weeks' gestation, to protect baby from whooping cough.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

3rd International Conference on Reproductive Health and Medicine, May 21-22, 2018 Vienna, Austria; 4th Annual Congress and Medicare Expo on Trauma & Critical Care, February 22-23, 2018 Paris, France; 47th Global Nursing & Healthcare Conference, March 01-03, 2018 London, UK; 7th World Congress on Breast Cancer, May 10-11, 2018 Frankfurt, Germany; 13th World Congress on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 27th International Conference on Oncology Research & Cancer Stem Cells, May 10-12, 2018 Frankfurt, Germany; 28th Euro Congress on Cancer Science & Therapy, August 09-10, 2018 Madrid, Spain; 11th European Breast Cancer Conference (EBCC-11), March 21-23, 2018 Barcelona, Spain; 35thAnnual Miami Breast Cancer Conference, March 8-11, 2018 Florida, USA; A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Cancer Treatments Conference, February 1- 3, 2018, Amsterdam, Netherlands; Radiation Break-through: from DNA damage responses to precision cancer therapy, March 12 – 14, 2018 Oxford, UK; Molecular Pathology Approach to Cancer, Amsterdam, Netherlands, 4 - 6 June 2018; 25th Biennial Congress of the European Association for Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; World Cancer Congress, October 1-4 2018 Kuala Lumpur, Malaysia; Conference on Cancer Immunotherapy: Combinations (C5), March 23-27, 2018, Québec, Canada; ESMO 2017 Congress-Integrating science into oncology for a better patient outcome, September 08-12 2017 Madrid, Spain; 37th Annual Pregnancy Meeting, January 23 - 28, 2017 Las Vegas, USA

Related Societies:

Europe:

Slovenian Association for Allergology & Clinical ImmunologySpanish Society of Allergology and Clinical ImmunologyEuropean Federation for ImmunogeneticsEuropean Macrophage and Dendritic Cell Society

USA:

American Association of ImmunologistsAmerican Association of Pharmaceutical ScientistsAmerican Association of Veterinary ImmunologistsAmerican Society for Histocompatibility and Immunogenetics

Asia and Middle-East:

Israel Association of Allergy and Clinical ImmunologyJordanian Society for Allergy and Clinical ImmunologyKuwait Society of Allergy & Clinical Immunology; Japanese Society for Immunology, Japan; Singaporean Society For Immunology, Singapore; Australasian Society of Clinical Immunology and Allergy, Australia

Track 8:  Vaccine Adjuvants & Delivery Technologies

Vaccine adjuvants is an ingredient of a vaccine that helps create a stronger immune response in the patient’s body.  In other words, adjuvants help vaccines work better. Some vaccines made from weakened or dead germs contain naturally occurring adjuvants and help the body produce a strong protective immune response. However, most vaccines developed today include just small components of germs, such as their proteins, rather than the entire virus or bacteria. These vaccines often must be made with adjuvants to ensure the body produces an immune response strong enough to protect the patient from the germ he or she is being vaccinated against. Aluminum gels or aluminum salts are vaccines ingredients that have been used in vaccines since the 1930s.  Small amounts of aluminum are added to help the body build stronger immunity against the germ in the vaccine. Aluminum is one of the most common metals found in nature and is present in air, food, and water. The amount of aluminum present in vaccines is low and is regulated by the U.S. Food and Drug Administration (FDA).

Drug delivery systems are engineered technologies for the targeted delivery and/or controlled release of therapeutic agents. Drugs have long been used to improve health and extend lives. The practice of drug delivery has changed dramatically in the last few decades and even greater changes are anticipated in the near future. Biomedical engineers have not only contributed substantially to our understanding of the physiological barriers to efficient drug delivery—such as transport in the circulatory system and drug movement through cells and tissues—they have contributed to the development of a number of new modes of drug delivery that have entered clinical practice.  Role of vaccine delivery technologies includes rational development of vaccines, achieving immunization goals, supporting best clinical practice.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

10th International Virology Congress and Expo, July 02-04, 2018 Vienna, Austria; 8th Global Summit on Microbiology & Infectious Diseases, February 22-23, 2018 Paris, France; 16th International Pharmaceutical Microbiology and Biotechnology Conference, May 21-23, 2018 Vienna, Austria; 4th World Congress and Expo on Applied Microbiology, November 29-December 01, 2017 Madrid, Spain; 8th Clinical Microbiology Conference, October 26-28, 2017 Paris, France; 46th World Congress on Microbiology, September 18-19, 2017 Dublin, Ireland; 13th World Congress on Healthcare & Technologies, June 14-15, 2018 Dublin, Ireland; British Society for Immunology Congress 2017, December 04-07, 2017 Brighton, UK; Keystone Symposium: Conference on Cancer Immunotherapy: Combinations, March 23-27, 2018 Montreal, Canada; Keystone Symposium on HIV and Co-infections: Pathogenesis, Inflammation and Persistence, April 15-19 2018 Whistler, Canada; Immunochemistry and Immunobiology Conference, June 10-15, 2018 West Dover, USA; Mechanisms in Immunity and Autoimmunity conference, June 17-21, 2018 Dresden, Germany; Gordon Research Conference: Cell Death, August 05–10, 2018 Newry, USA; 25th Biennial Congress of the European Association for Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; World Cancer Congress, October 1-4 2018 Kuala Lumpur, Malaysia; ESMO 2017 Congress-Integrating science into oncology Cnference for a better patient outcome, September 08-12 2017 Madrid, Spain; 37th Annual Pregnancy Meeting, January 23 - 28, 2017 Las Vegas, USA

Related Societies:

Europe:

European Society for ImmunodeficiencyFrench Society of Immunology; Immunology of Diabetes SocietyDeutsche Gesellschaft für Immunologie

USA:

American Academy of Paediatrics (AAP); American College Health Association (ACHA); Association of Immunization Managers (AIM); Association for Professionals in Infection Control and Epidemiology (APIC)

Asia and Middle-East:

Asia Pacific Association of Allergy, Asthma, and Clinical Immunology (APAAACI); Asia Pacific Association of Pediatric Allergy, Respirology and Immunology (APAPARI); Commonwealth of Independent States Society of Allergology and Immunology (CIS Society)

Track 9: Veterinary vaccines

Veterinary vaccines are to improve the health and welfare of companion animals, increase production of livestock in a cost-effective manner, and prevent animal-to-human transmission from both domestic animals and wildlife. Several vaccine types can de distinguished among the second-generation veterinary vaccines, depending whether they are live or inactivated, according to the strain of rabies virus used and the characteristics of the cell substrate chosen for viral replication. More recently a third generation of live veterinary rabies vaccine has been developed using recombinant technology. Depending upon the expression system these vaccines are used either parenterally or orally. Oral rabies vaccines are widely used in foxes in Europe and in racoons in the USA.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

5th International congress on Infectious Diseases, March 1-2, 2018 Berlin, Germany; 4th World Congress on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; International Conference on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 13th World Congress on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 6th Euro-Global Conference on Infectious Diseases, September 7-9, 2017 Paris, France; 3rd International Conference on Influenza and Zoonotic Diseases, August 21-22, 2017 Birmingham, UK; 90thAnnual Western Veterinary Conference, March 4-8, 2018 Las Vegas, USA; The Midwest Veterinary Conference (MVC), February 22-25, 2018 Ohio, Canada; VMX: Veterinary Meeting & Expo, February 3-7, 2018,  Florida, USA; World Veterinary Vaccine Congress, October 10-12, 2017 Barcelona, Spain; Eurasia Veterinary Conference 2018, February 19-23, 2018 Zanzibar, Tansania; 33rd World Veterinary Congress, August 27-31, 2017 Incheon, Republic of Korea ; WAAVP 2017 - The 26th International Conference of the World Association for the Advancement of Veterinary Parasitology, September 04-08, 2017 Kuala Lumpur, Malaysia

Related Societies:

Europe:

European Academy of Allergy and Clinical Immunology (EAACI); European Molecular Biology Laboratory (EMBL);  Medical Research Council (MRC) 

USA:

Hepatitis B Foundation (HBF); Infectious Diseases Society of America (IDSA); National Adult and Influenza Immunization Summit (NAIIS); National Foundation for Infectious Diseases (NFID); Paediatrics Infectious Diseases Society (PIDS)

Asia and Middle-East:

Russian Association of Allergology and Clinical ImmunologyTurkish National Society of Allergy and Clinical ImmunologyUkrainian Association of Allergologists and Clinical Immunologists

Track 10:  Geriatric Immunization

Vaccines are an important part of routine preventive care for older adults, but most adults don’t get their vaccines as recommended. Omitting vaccination leaves adults needlessly vulnerable to severe illnesses, long-term suffering and death from preventable infections. Vaccines are recommended for adults of all ages, they are particularly important for older persons who are at great risk of serious debilitating consequences and death from infectious diseases. Vaccination is particularly important for individuals living in nursing homes or assisted living facilities, as disease can spread easily among people in close proximity.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

6th Euro-Global Conference on Infectious Diseases, September 7-9, 2017 Paris, France; 5th  International congress on Infectious Diseases, March 1-2, 2018 Berlin, Germany; 4th World Congress on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; International Conference on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 13th World Congress on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 7th International Conference on Geriatrics and Palliative Care, September 4-5, 2017 Edinburgh, Scotland; EUGMS 2018 -The 14thInternational Congress of the European Union Geriatric Medicine Society, October 10-12, 2018 Berlin, Germany; American Geriatrics Society Annual Scientific Meeting 2018, May 3-5 2018 Orlando, USA; 24th Nordic Congress of Gerontology, May 2-4 2018 Oslo, Norway; Annual Scientific Meeting of the American Geriatrics Society (AGS), May 3 -5 Orlando, USA; Mena Geriatrics Summit 2017, November 2-3, 2017 Dubai, UAE; Australian Association of Gerontology 50th National Conference 2017, November 08-10, 2017 Burswood , Australia; International Society of Geriatric Oncology Conference 2017, November 9-11, 2017 Warsaw, Poland; British Geriatrics Society Autumn Scientific Meeting 2017, November 22-24, 2017 London , UK; 16th  Annual Mild Cognitive Impairment Symposium, Special Topic Workshop & Alzheimer's Public Forum 2018, January 20-21, 2018 Florida, USA

Related Societies:

Europe:

British Society for Allergy and Clinical ImmunologyBritish Society for Histocompatibility and ImmunogeneticsEuropean Federation of Immunological SocietiesEuropean Academy of Allergology and Clinical Immunology

USA:

Voices For Vaccines (VFV); National Institute of Allergy and Infectious Disease (NIAID); American Public Health Association (APHA); American Association for the Advancement of Science (AAAS); American Society for Microbiology (ASM)

Asia and Middle-East:

Australasian Society for ImmunologyAustralasian Society of Clinical Immunology and AllergyIsrael Association of Allergy and Clinical ImmunologyJordanian Society for Allergy and Clinical Immunology; Japanese Society for Immunology, Japan

Track 11: Vaccines against Viral and Bacterial Diseases

Most vaccines against viral infection are effective at preventing disease. However, they are not 100% effective for a number of reasons, reactions can occur after vaccinations.

It is difficult for many of us today to appreciate the dangers of childhood viral infections.

Most of the vaccines in use against viruses are very effective at preventing disease. However, for a variety of reasons, they can fail:

  • The vaccine becomes inactive due to incorrect storage, if used past its expiry date, or if incorrectly administered.
  • Individuals unpredictably fail to produce an adequate immune response to the vaccine.
  • Vaccine immunity “fades” over time.

 The different vaccine combinations at each time point do not interfere with one another and there is no increased risk of serious side-effects when they are given at the same time.

Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Antibodies are built against that particular bacteria, and prevents bacterial infection later.

Most vaccines against bacterial infections are effective at preventing disease, reactions can occur after vaccinations. Vaccines are available against tuberculosisdiphtheriatetanuspertussis, Haemophilus influenzae type B, cholera, typhoid, and Streptococcus pneumoniae.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

5th International congress on Infectious Diseases, March 1-2, 2018 Berlin, Germany; 4th World Congress on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; International Conference on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 13th World Congress on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 6th Euro-Global Conference on Infectious Diseases, September 7-9, 2017 Paris, France; 3rd International Conference on Influenza and Zoonotic Diseases, August 21-22, 2017 Birmingham, UK; 18th International Congress on Infectious Diseases, March 1-4, 2018 Buenos, Argentina; The European Congress of Clinical Microbiology and Infectious Diseases, April 21-24, 2018 Madrid, Spain; ICID 2018; 20th International Conference on Infectious Diseases, January 29-30, 2018 Sydney, Australia; Twelfth Annual Congress on Infectious Diseases Update for Primary Care and Hospital Medicine, September 14-15, 2017 Baltimore, USA; 30th Annual Conference on Infectious Diseases in Children, November 18-19, 2017 New York, USA; Conference on Infectious Diseases: Adult Issues in the Outpatient and Inpatient Settings, April 02-06, 2018 Florida, USA; ID Week 2017 Infectious Diseases Society of America Conference (IDSA), October 4-7, 2017 California, USA; 10th World Congress of the World Society of Pediatric Infectious Diseases (WSPID), December 2-5, 2017 Shenzhen, China

Related Societies:

Europe:

European Society for Paediatric Infectious Diseases; European Union Geriatric Medicine Society; European Federation of Immunological SocietiesEuropean Academy of Allergy and Clinical Immunology

USA:

The Anti-Vaccination Society of AmericaInfectious Diseases Society of AmericaAssociation of Immunization ManagersClinical Immunology Society

Asia and Middle-East:

Japanese Society for ImmunologySingaporean Society for ImmunologyAustralasian Society of Clinical Immunology and Allergy

Track 12: Human Preventive & Therapeutic Vaccines

preventative vaccine is administered to a person who is free of the targeted infection. By introducing a part of the virus or an inactive virus (which acts like a decoy) into the body, the immune system reacts by producing antibodies. Preventive vaccines are widely used to prevent diseases like poliochicken poxmeasles, mumps, rubella, influenza (flu), and hepatitis A and B.

In addition to preventive vaccines, there are also “therapeutic vaccines”. These are vaccines that are designed to treat people who already have a disease. Some scientists prefer to refer to therapeutic vaccines as “therapeutic immunogens.

Related Vaccines Conferences Immunology Conferences | World Vaccine Congress

29th International Conference on Vaccines and Immunization, March 19-20, 2018 London, UK; 9th Molecular Immunology & Immunogenetics Congress, March 08-09, 2018 London, UK; 9th European Immunology Conference, June 14-16, 2018 Rome, Italy; 2nd International Conference on Autoimmunity, November 06-07, 2017 Frankfurt, Germany; 11th International Conference on Allergy, Asthma & Clinical Immunology, September 07-08, 2017 Edinburgh, Scotland; 5th International congress on Infectious Diseases, March 1-2, 2018 Berlin, Germany; International Conference on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 4th ESCMID Conference on Vaccines, September 8-10, 2017 Dubrovnik, Croatia; 2017 International Society for Vaccines (ISV) Annual Congress, October 5-7, 2017 Paris, France; Vaccines Research & Development Summit 2017, November 20-22, 2017, Valencia, Spain; 2nd Global Conference on Vaccines Research, March 19-20, 2018 London, UK; World Vaccine Congress Washington 2018, April 3-5, 2018 Washington DC, USA; Global Congress on Vaccines and Vaccination Techniques, April 16-18, 2018, Dubai, UAE; 4th  Global Conference on Virology and Vaccines, April 19-21, 2018 Valencia, Spain; 48th National Immunization Conference, May 15-17, 2018 Atlanta, USA; Vaccines Technology Conference VII, June 17-22, 2018 Quebec, Canada; HIV Research for prevention conference (HIVR4P) October 21-25, 2018 Madrid, Spain

Related Societies:

Europe:

European Academy of Paediatrics; European Malaria Foundation (e-malaria Foundation); European Malaria Vaccine Development (EUROMALVAC); European malaria Vaccine Initiative (EMVI)

USA:

Autism Science Foundation (ASF); Childhood Influenza Immunization Coalition (CIIC); Edward Jenner Vaccine SocietyGlobal Polio Eradication Initiative    

Asia and Middle-East:

Lebanese Society of Allergy and ImmunologyMoldavian Society of Allergology & ImmunologyMoroccan Society of Allergology and Clinical Immunology

Track 13:  Hepatitis Vaccines

Hepatitis is an inflammation of the liver. The condition can be self-limiting or can progress to fibrosis (scarring), cirrhosis or liver cancer. Hepatitis viruses are the most common cause of hepatitis in the world but other infections, toxic substances (e.g. alcohol, certain drugs), and autoimmune diseases can also cause hepatitis.

There are 5 main hepatitis viruses, referred to as types A, B, C, D and E. These 5 types are of greatest concern because of the burden of illness and death they cause and the potential for outbreaks and epidemic spread. In particular, types B and C lead to chronic disease in hundreds of millions of people and, together, are the most common cause of liver cirrhosis and cancer.

Hepatitis A and E are typically caused by ingestion of contaminated food or water. Hepatitis B, C and D usually occur as a result of parenteral contact with infected body fluids. Common modes of transmission for these viruses include receipt of contaminated blood or blood products, invasive medical procedures using contaminated equipment and for hepatitis B transmission from mother to baby at birth, from family member to child, and also by sexual contact.

Acute infection may occur with limited or no symptoms, or may include symptoms such as jaundice (yellowing of the skin and eyes), dark urine, extreme fatigue, nausea, vomiting and abdominal pain.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

5th World Congress on Hepatitis & Liver Diseases, August 10-12, 2017 London, UK; 12th Euro-Global Gastroenterology Conference, September 11-12, 2017 Paris, France; 2nd International Conference on Digestive Diseases, December 07-08, 2017 Madrid, Spain; 12th International Conference on Abdominal Imaging and Endoscopy, April 10-12, 2018 Amsterdam, Netherlands; 2nd International Conference on Digestive Diseases, December 07-08, 2017 Madrid, Spain; 20th International Conference on Viral Hepatitis and Liver Disease, May 14-15, 2018 London, United Kingdom; International Congress of Paris Hepatology Conference 2018 January 15-16, 2018 Paris, France; 11th Australasian Viral Hepatitis Conference, 13-15 August 2018 Adelaide, Australia; AFRAVIH 2018: 9th edition of the International Francophone Conference on HIV/Hepatitis, April 4 -7 2018 Paris, France; The European Congress of Clinical Microbiology and Infectious Diseases, April 21-24, 2018 Madrid, Spain; ICID 2018; 20th International Conference on Infectious Diseases, January 29-30, 2018 Sydney, Australia; Twelfth Annual Conference on Infectious Diseases Update for Primary Care and Hospital Medicine, September 14-15, 2017 Baltimore, USA; 24th International Symposium on Hepatitis C Virus and Related Viruses, September 25-28 2017 Massachusetts, USA; World Hepatitis Summit 2017, November 1-3 2017, São Paulo, Brazil; 24th International Symposium on Hepatitis C Virus and Related Viruses (HCV 2017), September 25-28, 2017 Cape Cod, USA

Related Societies:

Europe:

British Society for ImmunologyMicrobiology Society, London; Society for Applied MicrobiologyEuropean Society of Clinical Microbiology and Infectious Diseases

USA:

The Federation of Clinical Immunology Societies; The American Association of ImmunologistsAmerican Society for MicrobiologyColombian Allergy, Asthma and Immunology AssociationCanadian Society for Immunology

Asia and Middle-East:

Indian society of Allergy, Asthma and Clinical ImmunologyAustralasian Society of Clinical Immunology and AllergyBangladesh Society of Allergy and Immunology

Track 14: DNA Vaccines

DNA vaccination is a technique for protecting an animal against disease by injecting it with genetically engineered DNA so cells directly produce an antigen, resulting in a protective immunological response.

Vaccination consists of stimulating the immune system with an infectious agent, or components of an infectious agent, modified in such a manner that no harm or disease is caused, but ensuring that when the host is confronted with that infectious agent, the immune system can adequately neutralize it before it causes any ill effect. For over a hundred years vaccination has been effected by one of two approaches: either introducing specific antigens against which the immune system reacts directly; or introducing live attenuated infectious agents that replicate within the host without causing disease synthesize the antigens that subsequently prime the immune system.

The field of DNA vaccination is developing rapidly. Vaccines currently being developed use not only DNA, but also include adjuncts that assist DNA to enter cells, target it towards specific cells, or that may act as adjuvants in stimulating or directing the immune response. Ultimately, the distinction between a sophisticated DNA vaccine and a simple viral vector may not be clear. Many aspects of the immune response generated by DNA vaccines are not understood. However, this has not impeded significant progress towards the use of this type of vaccine in humans, and clinical trials have begun.

Related Vaccines Conferences Immunology Conferences | World Vaccine Congress

6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 29thInternational Conference on Vaccines and Immunization, March 19-20, 2018 London, UK ; 5th International Conference on HIV/AIDS, STDs and STIs, November 13-14, 2017 Las Vegas, Nevada, USA; 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; 9th European Immunology Conference, June 14-16, 2018 Rome, Italy; 2nd International Conference on Autoimmunity, November 06-07, 2017 Frankfurt, Germany; 11thInternational Conference on Allergy, Asthma & Clinical Immunology, September 07-08, 2017 Edinburgh, Scotland; 22nd International AIDS Conference (AIDS 2018) July 23-27 2018 Amsterdam, Netherlands; CHA 2018; 20thInternational Conference on HIV and AIDS, May 14 - 15, 2018 London, United Kingdom; The annual Conference on Retroviruses and Opportunistic Infections (CROI), March 4 -7, 2018 Massachusetts, USA; 12th Annual ACTHIV, April 5 - 7, 2018, Chicago, USA; 20th Bangkok International Symposium on HIV Medicine 2018, January 17 - 19, 2018, Bangkok, Thailand; 2nd International Workshop on Healthy Living for HIV Infected Individuals, September 01-02, 2017 Barcelona, Spain; 21st Annual United States Conference on AIDS (USCA),  September 07-09, 2017 Washington, DC, USA;16th European AIDS Conference, October 25-28, 2017 Mila, Italy; Australasian HIV & AIDS Conference 2017, November 06-08, 2017 Canberra,  Australia; ICASA 2017: International Conference on AIDS and STIs in Africa (ICASA), December 04-09, 2017; Côte d’Ivoire, West Africa

Related Societies:

Europe:

Albanian Society of Allergology and Clinical ImmunologyAustrian Society of Allergology and ImmunologyBelgian Society of Allergy and Clinical ImmunologyBritish Society of Allergy and Clinical Immunology

USA:

Argentine Association of Allergy and ImmunologyArgentine Society of Allergy and ImmunologyBrazilian Society of Allergy and ImmunologyChilean Society of Allergy and Immunology

 Asia and Middle-East:

Allergy & Immunology Society of Sri LankaAllergy and Clinical Immunology Society of SingaporeAllergy and Immunology Society of Thailand

Track 15: Mucosal vaccines

Most infectious agents enter the body at mucosal surfaces and therefore mucosal immune responses function as a first line of defence. Protective mucosal immune responses are most effectively induced by mucosal immunization through oral, nasal, rectal or vaginal routes, but the vast majority of vaccines in use today are administered by injection. Immunisation involves the delivery of antigens to the mucosal immune system (dispersed or organised into units such as Peyer’s patches in the intestine or the nasal-associated lymphoid tissue in the oropharangeal cavity). The antigen delivery systems may comprise a simple buffer solution with/without adjuvants or an advanced particulate formulation, such as liposomes or nanoparticles. The most commonly evaluated route for mucosal antigen delivery is oral, but other routes have also been explored.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

20th International Conference on Neonatology and Perinatology, December 04-06, 2017 Madrid, Spain; 15thInternational Conference on Pediatrics and Pediatric Cardiology, February 19-20, 2018 Paris, France; 20thInternational Conference on Pediatrics Primary Care, September 03-04, 2018 Zurich, Switzerland; 3rd International Conference on Pediatric Surgery, May 07-08, 2018 Frankfurt, Germany; 14th International Conference on Clinical Pediatrics, June 14-16, 2018 Rome, Italy; 17th Annual Congress on Pediatrics & Adolescent Medicine, July 09-10, 2018 Sydney, Australia; 21st Annual Congress on Neonatology & Pediatrics, May 30-31, 2018 Osaka, Japan; 39th National Conference on Pediatric Health Care National Association of Pediatric Nurse Practitioners, March 19-22, 2018 Chicago, USA; 4th ESCMID Conference on Vaccines, September 8-10, 2017 Dubrovnik, Croatia; 2017 International Society for Vaccines (ISV) Annual Congress, October 5-7, 2017 Paris, France; Vaccines R & D Summit 2017, November 20-22, 2017, Valencia, Spain; 2nd Global Conference and Expo on Vaccines Research, March 19-20, 2018 London, UK; World Vaccine Congress Washington 2018, April 3-5, 2018 Washington DC, USA; Global Congress on Vaccines and Vaccination Techniques, April 16-18, 2018, Dubai, UAE; 4th Global Conference on Virology and Vaccines, April 19-21, 2018 Valencia, Spain; 48th National Immunization Conference, May 15-17, 2018 Atlanta, USA; Vaccines Technology Conference VII, June 17-22, 2018 Quebec, Canada

Related Societies:

Europe:

Swiss Society for MicrobiologyFederation of European Microbiological SocietiesInternational Society of VaccinesInternational Union of Immunological Society

USA:

Ecuadorian Society of Allergy, Asthma, and ImmunologyGuatemalan Allergy, Asthma and Clinical Immunology AssociationHonduran Society of Allergy and Clincial Immunology

Asia and Middle-East:

Indonesian Society of Allergy and ImmunologyKorean Academy of Asthma, Allergy and Clinical ImmunologyMalaysian Society of Allergy and Immunology

Track 16: Plant-based vaccines

Plant-based vaccines are recombinant protein subunit vaccines. Ideally, the choice of plant species used to produce the selected antigen should allow for oral drug delivery in the form of an edible vaccine. To date, the most advanced human vaccine projects have successfully completed phase I clinical trials, and animal vaccine projects have given promising data in early phase trials targeting specific animal species.

The plant-based vaccine production method works by isolating a specific antigen protein, one that triggers a human immune response from the targeted virus. A gene from the protein is transferred to bacteria, which are then used to “infect” plant cells. The plants then start producing the exact protein that will be used for vaccinations. The flexibility of the plant expressed vaccine system, combined with its low cost and ability to massively scale may provide vaccine protection not only to citizens of the United States, but to many parts of the world that cannot currently afford vaccines. Other uses of plant expressed vaccines including the successful creation of edible bananas that protect against the Norwalk virus.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

6th Euro-Global Conference on Infectious Diseases, September 7-9, 2017 Paris, France; 5th  International congress on Infectious Diseases, March 1-2, 2018 Berlin, Germany; 4th World Congress on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; International Conference on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 13th World Congress on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; 3rd International Conference on Flu and Emerging Infectious Diseases, November 06-07, 2017 Las Vegas, Nevada, USA; 18th International Congress on Infectious Diseases, March 1-4, 2018 Buenos, Argentina; The European Congress of Clinical Microbiology and Infectious Diseases, April 21-24, 2018 Madrid, Spain; ICID 2018 : 20th International Conference on Infectious Diseases, January 29-30, 2018 Sydney, Australia; Twelfth Annual Infectious Diseases Update for Primary Care and Hospital Medicine, September 14-15, 2017 Baltimore, USA; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 New York, USA; Infectious Diseases: Adult Issues in the Outpatient and Inpatient Settings, April 02-06, 2018 Florida, USA; IDWeek 2017 Conference of the Infectious Diseases Society of America (IDSA), October 4-7, 2017 California, USA; 10th World Congress of the World Society of Pediatric Infectious Diseases (WSPID), December 2-5, 2017 Shenzhen, China

Related Societies:

Europe:

Croatian Society of Allergology and Clinical Immunology; Czech Society of Allergology and Clinical ImmunologyFinnish Society of Allergology and Clinical ImmunologyFrench Society of Allergology and Clinical Immunology

USA:

Panamanian Association of Allergology and Clinical ImmunologyParaguayan Society of Allergy, Asthma, and ImmunologyPeruvian Society of Allergy and ImmunologyVenezuelan Society of Allergy, Asthma and Immunology

Asia and Middle-East:

Philippine Society of Allergy, Asthma and ImmunologyTaiwan Academy of Pediatric Allergy Asthma ImmunologyVietnam Association of Allergy, Asthma and Clinical Immunology

Track 17: HPV Vaccines

Human Papillomavirus (HPV) vaccine is an inactivated (not live) vaccine which protects against four major types of HPV.

These include two types that cause about 70% of cervical cancer and two types that cause about 90% of genital warts. HPV vaccine can prevent most genital warts and most cases of cervical cancer. Protection from HPV vaccine is expected to be long-lasting. But vaccinated women still need cervical cancer screening because the vaccine does not protect against all HPV types that cause cervical cancer.

Routine HPV Vaccination                                           

  • HPV vaccine is routinely recommended for girls 11 and 12 years of age
  • The HPV4 vaccine (the type recommended for prevention of genital warts in girls) may also be given in three doses to boys aged 9 to 26.

It is important for girls to get HPV vaccine before their first sexual contact -- because they have not been exposed to HPV.  For these girls, the vaccine can prevent almost 100% of disease caused by the four types of HPV targeted by the vaccine. However, if a girl or woman is already infected with a type of HPV, the vaccine will not prevent disease from that type. The vaccine is also recommended for girls and women 13 through 26 years of age who did not receive it when they were younger.

Related Vaccines Conferences Immunology Conferences | World Vaccine Congress

10th International Virology Congress and Expo, July 02-04, 2018 Vienna, Austria; 8th Global Summit on Microbiology & Infectious Diseases, February 22-23, 2018 Paris, France; 16th International Pharmaceutical Microbiology and Biotechnology Conference, May 21-23, 2018 Vienna, Austria; 4th World Congress and Expo on Applied Microbiology, November 29-December 01, 2017 Madrid, Spain; 8th Clinical Microbiology Conference, October 26-28, 2017 Paris, France; 46th World Congress on Microbiology, September 18-19, 2017 Dublin, Ireland; 13th World Congress on Healthcare & Technologies, June 14-15, 2018 Dublin, Ireland; British Society for Immunology Congress 2017, December 04-07, 2017 Brighton, UK; Keystone Symposium on Cancer Immunotherapy: Combinations, March 23-27, 2018 Montreal, Canada; Keystone Symposium on HIV and Co-infections: Pathogenesis, Inflammation and Persistence, April 15-19 2018 Whistler, Canada; Immunochemistry and Immunobiology conference, June 10-15, 2018 West Dover, USA; Mechanisms in Immunity and Autoimmunity conference, June 17-21, 2018 Dresden, Germany; Gordon Research Conference: Cell Death, August 05–10, 2018 Newry, USA; 25th Biennial Congress of the European Association for Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; World Cancer Congress, October 1-4 2018 Kuala Lumpur, Malaysia; Conference on Cancer Immunotherapy: Combinations (C5), March 23-27, 2018, Québec, Canada; ESMO 2017 Congress-Integrating science into oncology for a better patient outcome, September 08-12 2017 Madrid, Spain; 37th Annual Pregnancy Meeting, January 23 - 28, 2017 Las Vegas, USA

Related Societies:

Europe:

Slovenian Association for Allergology & Clinical ImmunologySpanish Society of Allergology and Clinical ImmunologyEuropean Federation for ImmunogeneticsEuropean Macrophage and Dendritic Cell Society

USA:

American Association of ImmunologistsAmerican Association of Pharmaceutical ScientistsAmerican Association of Veterinary ImmunologistsAmerican Society for Histocompatibility and Immunogenetics

Asia and Middle-East:

Israel Association of Allergy and Clinical ImmunologyJordanian Society for Allergy and Clinical ImmunologyKuwait Society of Allergy & Clinical Immunology; Japanese Society for Immunology, Japan; Singaporean Society For Immunology, Singapore; Australasian Society of Clinical Immunology and Allergy, Australia

Track 18: Travel Immunization

Anyone planning to travel abroad may need immunizations before departure. Although few immunizations are compulsory for international travel, some are recommended for the traveller’s protection. Some vaccines must be given in 2–3 doses several weeks apart. Therefore, a doctor should be consulted at least 2–3 months before departure. Children under 1 year, and people with a compromised immune system or serious underlying disorder may not be able to have some vaccinations, such as those for yellow fever and tuberculosis (BCG). Recommended vaccines are travel vaccinations that can protect you in areas where there is an intermediate or high risk for contracting certain illnesses. They also help prevent the spread of diseases from one country to another.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

20th International Conference on Neonatology and Perinatology, December 04-06, 2017 Madrid, Spain; 15thInternational Conference on Pediatrics and Pediatric Cardiology, February 19-20, 2018 Paris, France; 20thInternational Conference on Pediatrics Primary Care, September 03-04, 2018 Zurich, Switzerland; 3rd International Conference on Pediatric Surgery, May 07-08, 2018 Frankfurt, Germany; 14th International Conference on Clinical Pediatrics, June 14-16, 2018 Rome, Italy; 17th Annual Congress on Pediatrics & Adolescent Medicine, July 09-10, 2018 Sydney, Australia; 21st Annual Congress on Neonatology & Pediatrics, May 30-31, 2018 Osaka, Japan; 39th National Conference on Pediatric Health Care National Association of Pediatric Nurse Practitioners, March 19-22, 2018 Chicago, USA; 4th ESCMID Conference on Vaccines, September 8-10, 2017 Dubrovnik, Croatia; 2017 International Society for Vaccines (ISV) Annual Congress, October 5-7, 2017 Paris, France; Vaccines R & D Summit 2017, November 20-22, 2017, Valencia, Spain; 2nd Global Conference and Expo on Vaccines Research, March 19-20, 2018 London, UK; World Vaccine Congress Washington 2018, April 3-5, 2018 Washington DC, USA; Conference on Vaccines and Vaccination Techniques, April 16-18, 2018, Dubai, UAE; 4th Global Conference Virology and Vaccines, April 19-21, 2018 Valencia, Spain; 48th National Immunization Conference, May 15-17, 2018 Atlanta, USA; Vaccine Technology VII, June 17-22, 2018 Quebec, Canada; HIV Research for prevention conference (HIVR4P) October 21-25, 2018 Madrid, Spain

Related Societies:

Europe:

European Society for ImmunodeficiencyFrench Society of Immunology; Immunology of Diabetes SocietyDeutsche Gesellschaft für Immunologie

USA:

American Academy of Paediatrics (AAP); American College Health Association (ACHA); Association of Immunization Managers (AIM); Association for Professionals in Infection Control and Epidemiology (APIC)

Asia and Middle-East:

Asia Pacific Association of Allergy, Asthma, and Clinical Immunology (APAAACI); Asia Pacific Association of Pediatric Allergy, Respirology and Immunology (APAPARI); Commonwealth of Independent States Society of Allergology and Immunology (CIS Society)

Track 19: Vaccines for Vector-borne Diseases

Vaccines that target blood-feeding disease vectors, such as mosquitoes and ticks, have the potential to protect against the many diseases caused by vector-borne pathogens. Vector-borne diseases are among the most complex of all infectious diseases to prevent and control. Vector- borne diseases, most of which are transmitted in and around the home, are best controlled by a combination of vector control (use of public health insecticides on bednets, or by spraying), medicines and vaccines.

Historically, successful vector-borne disease prevention resulted from management or elimination of vector populations.  Malaria was driven out of the USA and most of Europe in this way. Where vector control has been consistently applied in the past, the results have been dramatic, especially with early efforts to control malaria by spraying the inside surfaces of houses with insecticides. Indoor Residual Spraying (IRS) and long-lasting insecticide treated bednets have been very effective over the last 10 years and are widely regarded as one of the main contributors to the more than 1 million lives saved.

In contrast to expenditure and effort on medicine, diagnostic and vaccine development, relatively little attention was given to vector control in the past.  The foresighted establishment of IVCC in 2005, with a grant from the Bill and Melinda Gates Foundation began the process of bringing Vector Control into the mainstream strategy for future eradication of malaria and other vector-borne diseases.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

5th World Congress on Hepatitis & Liver Diseases, August 10-12, 2017 London, UK; 12th Euro-Global Gastroenterology Conference, September 11-12, 2017 Paris, France; 2nd International Conference on Digestive Diseases, December 07-08, 2017 Madrid, Spain; 12th International Conference on Abdominal Imaging and Endoscopy, April 10-12, 2018 Amsterdam, Netherlands; 2nd International Conference on Digestive Diseases, December 07-08, 2017 Madrid, Spain; 20th International Conference on Viral Hepatitis and Liver Disease, May 14-15, 2018 London, United Kingdom; International Congress of Paris Hepatology Conference 2018 January 15-16, 2018 Paris, France; 11th Australasian Viral Hepatitis Conference, 13-15 August 2018 Adelaide, Australia; AFRAVIH 2018: 9th edition of the International Francophone Conference on HIV/Hepatitis, April 4 -7 2018 Paris, France; 24th International Symposium on Hepatitis C Virus and Related Viruses, September 25-28 2017 Massachusetts, USA; World Hepatitis Summit 2017, November 1-3 2017, São Paulo, Brazil; 24th International Symposium on Hepatitis C Virus and Related Viruses (HCV 2017), September 25-28, 2017 Cape Cod, USA

Related Societies:

Europe:

European Academy of Allergy and Clinical Immunology (EAACI); European Molecular Biology Laboratory (EMBL);  Medical Research Council (MRC) 

USA:

Hepatitis B Foundation (HBF); Infectious Diseases Society of America (IDSA); National Adult and Influenza Immunization Summit (NAIIS); National Foundation for Infectious Diseases (NFID); Paediatrics Infectious Diseases Society (PIDS)

Asia and Middle-East:

Russian Association of Allergology and Clinical ImmunologyTurkish National Society of Allergy and Clinical ImmunologyUkrainian Association of Allergologists and Clinical Immunologists

Track 20: Tuberculosis Vaccines

BCG, or bacille Calmette-Guerin (Tuberculosis Vaccines), is a vaccine for tuberculosis (TB) disease. Many foreign-born persons have been BCG-vaccinated. BCG is used in many countries with a high prevalence of TB to prevent childhood tuberculous meningitis and miliary disease. However, Tuberculosis Vaccine is not generally recommended for use in the United States because of the low risk of infection with Mycobacterium tuberculosis, the variable effectiveness of the vaccine against adult pulmonary TB, and the vaccine’s potential interference with tuberculin skin test reactivity. The Tuberculosis Vaccine should be considered only for very select persons who meet specific criteria and in consultation with a TB expert.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 29thInternational Conference on Vaccines and Immunization, March 19-20, 2018 London, UK ; 5th International Conference on HIV/AIDS, STDs and STIs, November 13-14, 2017 Las Vegas, Nevada, USA; 7th Asia Pacific STD and Infectious Diseases Congress, October 23-25, 2017 Osaka, Japan; 9th European Immunology Conference, June 14-16, 2018 Rome, Italy; 2nd International Conference on Autoimmunity, November 06-07, 2017 Frankfurt, Germany; 11thInternational Conference on Allergy, Asthma & Clinical Immunology, September 07-08, 2017 Edinburgh, Scotland; 22nd International AIDS Conference (AIDS 2018) July 23-27 2018 Amsterdam, Netherlands; CHA 2018; 20thInternational Conference on HIV and AIDS, May 14 - 15, 2018 London, UK; The annual Conference on Retroviruses and Opportunistic Infections (CROI), March 4 -7, 2018 Massachusetts, USA; 12th Annual ACTHIV, April 5 - 7, 2018, Chicago, USA; 20th Bangkok International Symposium on HIV Medicine 2018, January 17 - 19, 2018, Bangkok, Thailand; 2ndInternational Workshop on Healthy Living for HIV Infected Individuals, September 01-02, 2017 Barcelona, Spain; 21stAnnual United States Conference on AIDS (USCA),  September 07-09, 2017 Washington, DC, USA; European Workshop on Healthy Living with HIV, September 15-16, 2017 Barcelona, Spain; 16th European AIDS Conference, October 25-28, 2017 Mila, Italy; Australasian HIV & AIDS Conference 2017, November 06-08, 2017 Canberra,  Australia; ICASA 2017: International Conference on AIDS and STIs in Africa (ICASA), December 04-09, 2017; Côte d’Ivoire, West Africa; 48thUnion World Conference on Lung Health, October 11 -14 2017, Guadalajara, Mexico; Conference on Tuberculosis: Translating Scientific Findings for Clinical and Public Health Impact (X7), April 15—19, 2018 British Columbia, Canada

Related Societies:

Europe:

British Society for Allergy and Clinical ImmunologyBritish Society for Histocompatibility and ImmunogeneticsEuropean Federation of Immunological SocietiesEuropean Academy of Allergology and Clinical Immunology

USA:

Voices For Vaccines (VFV); National Institute of Allergy and Infectious Disease (NIAID); American Public Health Association (APHA); American Association for the Advancement of Science (AAAS); American Society for Microbiology (ASM)

Asia and Middle-East:

Australasian Society for ImmunologyAustralasian Society of Clinical Immunology and AllergyIsrael Association of Allergy and Clinical ImmunologyJordanian Society for Allergy and Clinical Immunology; Japanese Society for Immunology, Japan

Market Analysis

Conference Series Ltd. invites all the participants across the world to attend “30th Euro Global Summit and Expo on Vaccines & Vaccination” going to be held during June 14-16, 2018 in Barcelona, Spain. The Theme of the conference is "Roadmap on the future of Vaccines Research" will explore the advances in Vaccines and vaccination.

Importance & Scope:

This conference could be an exceptional event that brings along a novel and International mixture of huge and medium cognizance on vaccines and vaccination, leading universities engendering the conference an ideal platform to apportion expertise, foster collaborations across trade and world, and assess elevating technologies across the world.

Vaccination is a key to eradicate the diseases. It is a subject for the professionals who looks beyond the clinical prospects. Traditional approaches to vaccine design were to emasculate or inactivate the human pathogen or a cognate animal homologue, Vaccinology is the science of vaccine development and how the immune system responds to vaccines, but additionally includes perpetual evaluation of immunization programs and vaccine safety and efficacy, as well as surveillance of the epidemiology of vaccine-preventable diseases. This chapter provides a brief overview of some of the main concepts of immunology and Vaccinology as they relate to immunization. Euro Vaccines 2018 amasses all the extroverts under one roof of current advances.

Why Barcelona?

Spain’s second largest and definitely most cosmopolitan city, and one of the Mediterranean’s busiest ports. Barcelona is the capital of Catalonia, which is a region of Spain with its own language – Catalan, and its own culture and character. Barcelona is known throughout the world as a cultural city with considerable heritage and a permanent, dynamic offer, a rich architectural and monumental heritage with works that have been declared part of the world heritage by the UNESCO.

This city has the greatest concentration of top class universities in the world. The presence of universities, hospitals, labs and other professional services, together with key installations make it favourite destination for scientific meetings.

Hospitals Associated with Vaccines Research

Barcelona

  • Hospital of Barcelona
  • Hospital of Sant Pau
  • Hospital Vall d’Hebron
  • Hospital of Bellvitge
  • Hospital del Mar
  • Hospital Clinic of Barcelona
  • Hospital Quirónsalud Barcelona
  • Antonio Campoy SLU
  • Artro Esport SL
  • Artroscopia GC
  • Barcelona Spine Center
  • Centre Cardiovascular Sant Jordi
  • Centre Medic Medibaix
  • Centre Medic Sant Jordi de Sant Andreu
  • Centre Medico Tecno
  • Centre de Ginecologia I Obstetricia
  • Centro Medico Teknon
  • Centro de Diagnóstico por imagen foraste S.A.
  • Centro de Oftalmología Barraquer S.A.
  • Ciscar Laboratori SA
  • Clinic Barcelona
  • Clinica Baviera Barcelona
  • Clinica Claros
  • Clinica Diagonal-Clinica de Medicina Integral
  • Clinica MAZ (Sant Honorat)
  • Clinica Nuestra Senora Del Remedio
  • Clinica Quiron
  • Clinica Sagrada Familia
  • Clinica Sant Josep
  • Clinica Tres Torres
  • Clinica de Vic
  • EMSI - Equip Medic De Salut Integral S. L.
  • Hospital Del Mar
  • Hospital Quiron Barcelona
  • Hospital Sant Joan de Deu
  • Hospital de Sabadell
  • Idonabi
  • J. Sancho Serrats SL
  • Laboratorio Dr F. Echevarne Analisis S.A.
  • M.D.B
  • Policlinica Barcelona
  • Policlinica Del Valles
  • USP Centro de Cirugia Ambulatoria Planetarium
  • USP Instituto Oftalmologico de Barcelona
  • Vall d'Hebron Hospitals
  • Virgen De Nuria Centre Medic

Spain:

  • Joan XXIII Hospital - Tarragona
  • Hospital Santa Tecla - Tarragona
  • Hospital San Joan de Reus - Reus , Tarragona
  • Pius Hospital de Valls - Valls , Tarragona
  • Hospital Sant Joan de Déu Barcelona Link - Esplugues de Llobregat , Barcelona
  • Hospital Clínic Link - Barcelona
  • Parc Taulí Corporation - Sabadell
  • Hospital of Barcelona - Barcelona
  • Hospital of Bellvitge - l'Hospitalet de Llobregat , Barcelona
  • Hospital of the Vall d'Hebron - Barcelona
  • Hospital del Mar- Barcelona
  • Hospital de Sant Pau (until June 2009)
  • Hospital Quirón Barcelona [2] - Barcelona
  • Hospital Plató - Barcelona
  • Girona Nephrology and Dialysis Service [3] - Girona
  • Hospital Universitario Arnau de Vilanova - Lleida
  • Hospital Infanta Cristina de Badajoz
  • University Hospital Complex of A Coruña - A Coruña
  • University Hospital Complex of Santiago - Santiago de Compostela
  • Hospital Complex Architect Marcide - Professor Novoa Santos - Naval. Xerencia of the Area of ​​Ferrol - Ferrol
  • Public Foundation Virxe da Xunqueira Hospital - Cee, Galicia
  • Public Foundation Barbanza Hospital - Santa Mariña de Ribeira
  • Xeral-Calde Hospital Complex - Lugo
  • Hospital da Costa - Burela
  • Hospital Comarcal de Monforte - Monforte de Lemos
  • Pontevedra Hospital Complex - Pontevedra
  • University Hospital Complex Of Vigo - Vigo
  • Public Foundation Hospital do Salnés - Vilagarcía de Arousa
  • Ourense Hospital Complex - Ourense
  • Verín Hospital Foundation - Verín
  • Hospital Comarcal de Valdeorras - Valdeorras
  • Hospital San Pedro - Logroño
  • Hospital 12 de Octubre
  • Hospital Carlos III
  • Hospital Puerta del Hierro Majadahonda, Madrid
  • University Hospital La Paz
  • Moncloa Clinic
  • University Hospital Foundation Alcorcón
  • Hospital of Móstoles - Móstoles, Madrid
  • Hospital Quirón Madrid [4]
  • Hospital Ramón y Cajal
  • Hospital La Princesa
  • Child Jesus Hospital
  • Hospital Gregorio Marañón
  • Dam Hospital
  • Central Hospital of Defense (Military)
  • University Hospital Virgen de la Arrixaca- Murcia
  • University Hospital Morales Meseguer - Murcia
  • University Hospital Reina Sofía [1] - Murcia
  • USP Hospital San Carlos - Murcia
  • University Hospital Virgen del Rosell - Cartagena
  • General University Hospital of Santa Lucía - Cartagena
  • Hospital Nuestra Señora del Perpetuo Socorro - Cartagena
  • Hospital Naval - Cartagena
  • Santo Hospital de la Caridad - Cartagena
  • Virgen de la Caridad Medical Center - Cartagena
  • Rafael Mendez Hospital - Lorca
  • Hospital de la Vega Lorenzo Guirao - Cieza
  • Hospital Comarcal del Noroeste - Caravaca de la Cruz
  • Hospital Virgen del Castillo - Yecla
  • Hospital Los Arcos - San Javier, Murcia
  • Clinica Universitaria de Navarra Link - Pamplona
  • Hospital Universitari La Fe - Valencia
  • Hospital 9 d'Octubre - Valencia
  • Hospital Arnau de Vilanova - Valencia
  • Hospital Virgen del Consuelo - Valencia
  • Vazquez Bernabeu Military Hospital - Valencia
  • Nisa Hospital València al Mar - Valencia
  • Doctor Peset University Hospital - Valencia
  • Hospital Clínic Universitari - Valencia
  • Hospital la Malva-Rosa - Valencia
  • General University Hospital - Valencia
  • Clinica Quirón - Valencia
  • House of health - Valencia
  • Hospital of Manises - Manises
  • Hospital of Lliria - Lliria
  • Hospital Lluis Alcanyís - Xàtiva
  • Hospital Francesc de Borja - Gandia
  • Hospital of La Ribera - Alzira
  • General Hospital of Requena - Requena
  • General University Hospital of Castellón - Castellón de la Plana
  • Provincial Hospital of Castellón - Castellón de la Plana
  • University Hospital of La Plana - Villareal
  • Hospital Comarcal de Vinaròs - Vinaròs
  • Segorbe Auxiliary Hospital - Segorbe
  • Sagunto Hospital - Sagunto
  • Alicante / Alacant [ edit ]
  • General Hospital of Alicante - Alicante
  • University Hospital San Juan de Alicante - Alicante
  • General Hospital Plá - Alicante
  • University Hospital San Juan - San Juan de Alicante
  • General Hospital of Dénia (Marina Salud) - Dénia
  • Hospital Marina Baixa - Benidorm
  • University Hospital of Vinalopó - Elche
  • General Hospital of Elche - Elche
  • General Hospital of Elda - Elda
  • Public Hospital Virgen de Los Lirios - Alcoy
  • General Hospital of Ontinyent - Ontinyent
  • University Hospital of Torrevieja - Torrevieja

Worldwide:

  • Cleveland Clinic
  • St Jude Children's Research Hospital
  • Johns Hopkins Medicine                                                        
  • Mayo Clinic Scottsdale AZ
  • University of Maryland Medical Center
  • M D Anderson Cancer Center
  • Massachusetts General Hospital
  • Assistance Publique Hôpitaux de Paris
  • Memorial Sloan Kettering Cancer Center
  • New York Presbyterian / Lower Manhattan Hospital
  • Providence Health & Services
  • Deer's Head Hospital Center
  • Buddhist Tzu Chi General Hospital
  • Beth Israel Deaconess Medical Center Needham     
  • Aurora Health Care
  • Taipei Veterans General Hospital
  • Advocate Health Care
  • University of Pittsburgh Medical Center
  • Brigham and Women's Hospital
  • Hartford Hospital

Societies Associated with Vaccine Research

Spain

  • Spanish Association of Paediatrics
  • Spanish Society for Immunology
  • Spanish Society of Allergology and Clinical Immunology

Europe

  • European Federation of Immunological societies (EFIS)
  • Italian Society of Allergy, Asthma and Clinical Immunology
  • German Society for Allergology and Clinical Immunology
  • British Society of Allergy and Clinical Immunology
  • French Society of Allergology and Clinical Immunology
  • Dutch Society of Allergology
  • Romanian Society of Allergology and Clinical Immunology
  • Czech Society of Allergology and Clinical Immunology

Worldwide

  • The International Union of Immunological Societies
  • The Society for Mucosal Immunology
  • British Society for Immunology
  • Federation of African Immunological Societies
  • Federation of Clinical Immunology Societies
  • Infectious Diseases Society of America
  • Immune Deficiency Foundation
  • European Federation of Immunological Societies
  • Venezuelan Society of Allergy, Asthma and Immunology
  • Peruvian Society of Allergy and Immunology
  • Honduran Society of Allergy and Clincial Immunology
  • Guatemalan Allergy, Asthma and Clinical Immunology Association
  • Chilean Society of Allergy and Immunology
  • Brazilian Society of Allergy and Immunology
  • Argentine Society of Allergy and Immunology
  • Swiss Society of Allergology and Immunology
  • Slovenian Association for Allergology & Clinical Immunology
  • Serbian Association of Allergologists and Clinical Immunologists
  • Romanian Society of Allergology and Clinical Immunology (RSACI)
  • Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC)
  • celandic Society of Allergy and Clinical Immunology
  • Portuguese Society of Allergology and Clinical Immunology
  • Hungarian Society of Allergology and Clinical Immunology
  • Hellenic Society of Allergology and Clinical Immunology
  • German Society for Allergology and Clinical Immunology
  • French Society of Allergology and Clinical Immunology
  • Malaysian Society of Allergy and Immunology
  • Australasian Society of Clinical Immunology and Allergy
  • Russian Association of Allergology and Clinical Immunology
  • Georgian Association of Allergology and Clinical Immunology

Industries Associated with Vaccines Research

Barcelona:

  • Adienne Pharma & Biotech
  • Almirall
  • BCN Peptides
  • Biokit
  • Charles River Laboratories
  • Ferrer
  • Grifols
  • Menarini
  • Oryzon Genomics
  • Veeva Systems

Spain:

  • Aelix Therapeutics
  • Ferrer
  • Bial
  • GlaxoSmithKline
  • Biofabri
  • Nordvacc
  • Novartis vaccines and diagnostics sl.
  • Cooperativa Pharmaceuticals Ciudad Real
  • ANYSA GANADERA SL
  • VILA PEIRO, S.A.
  • Eli Lilly
  • Adienne Pharma & Biotech
  • Almirall
  • BCN Peptides
  • Biokit
  • Charles River Laboratories
  • Ferrer
  • Grifols
  • Menarini
  • Oryzon Genomics
  • Veeva Systems
  • Bayer
  • Acumed
  • Genomica
  • GlaxoSmithKline
  • Norgine
  • Pfizer
  • Pharmamar (Zeltia)
  • Teleflex Medical
  • 3P Biopharmaceuticals
  • Cinfa Biotech
  • Sofpromed
  • Syntax for Science
  • Lonza
  • Baxter
  • Praxis Pharmaceutical
  • Synthon
  • Ipsen
  • Biomedal
  • Amadix
  • Laboratorios IVEN

Worldwide: (Top Industries)

  • Abbott Labs
  • Altimmune
  • BiondVax Pharma
  • Dynavax Tech
  • Emergent Bio
  • Genocea Bio
  • GlaxoSmithKline
  • Heat Biologics
  • Inovio Pharma
  • Merck
  • Novartis
  • Novavax
  • Opko Health
  • Pfizer
  • Sanofi
  • Sinovac Biotech
  • VBI Vaccines
  • Vical Inc

Universities Associated with Vaccines Research

Barcelona:

  • University of Barcelona
  • Universitat Autònoma de Barcelona
  • Barcelona College of Chiropractic
  • Escuela Superior de MTC
  • Instituto Superior de Medicinas Tradicionales
  • Biodynamic Craniosacral Spanish Institute
  • Instituto Erich Fromm de Psicoterapia Integradora Humanista
  • Ramon Llull University
  • Nacar Clínicas Dentales

Spain

  • Universidad de Alcalá
  • Universidad Alfonso X El Sabio
  • Universitat Autònoma de Barcelona
  • Universidad Autónoma de Madrid
  • Universitat de Barcelona
  • Universidad de Cádiz
  • Universidad de Cantabria
  • Universidad de Castilla-La Mancha
  • Universidad de Castilla-La Mancha
  • Valencia Catholic University Saint Vincent Martyr
  • CEU San Pablo University
  • Universidad CEU Cardenal Herrera
  • Universidad Complutense de Madrid
  • Universidad de Córdoba
  • University of the Basque Country
  • Universidad Europea de Madrid
  • Universidad de Extremadura
  • Universidad Francisco de Vitoria
  • Universitat de Girona
  • Universidad de Granada
  • Universitat Internacional de Catalunya
  • Universidad de La Laguna
  • Universidad de Las Palmas de Gran Canaria
  • Universitat de Lleida
  • Universidad de Málaga
  • Miguel Hernández University of Elche
  • Universidad de Murcia
  • Universidad de Navarra
  • Universidad de Oviedo
  • Autonomous University of Barcelona
  • Universidad Rey Juan Carlos
  • Universitat Rovira i Virgili
  • Universidad de Salamanca
  • Universidad de Santiago de Compostela
  • Universidad de Sevilla
  • Universidad de Valladolid
  • Universitat de València
  • Universidad de Zaragoza

Worldwide:

  • Stanford University
  • Kingston University
  • London City University
  • Newman University
  • University of London
  • University of Oxford
  • University of Alabama

Market Growth of Vaccine Research in the last and upcoming ten years

The global vaccine market is one of the fastest growing segments and new predictions estimate the value of the market to reach between $48 billion and more than $70 billion over the next five to eight years.

According to a new report released by Transparency Market Research, the value of the global human vaccines market is expected to grow from a $28.3 billion in 2015 to $72.5 billion in 2024. The projection would represent a compound annual growth rate (CAGR) of 11.2% from 2016 to 2024. Even though the dollar figure is large and growing, vaccines still only account 3% of the market share within the global pharmaceutical industry. The report broke down expectations by segments. By age group, paediatric vaccines accounted for 57.5% of the share in 2015, but adult vaccines are expected to grow at a 13.2% CAGR during the forecast period. When the research group analysed the market by product, they found the pneumococcal segment to have the majority share in 2015, but expect hepatitis products to demonstrate strong growth through 2024. By vaccine type, the conjugate vaccines held the majority share in 2015, but the combination vaccines were expected to have the largest CAGR.

Past Conference Report

Euro Vaccines 2017

The 16th Euro Global Summit and Expo on Vaccines & Vaccination hosted by Conferenceseries Ltd during June 19-21, 2017 at Hotel Novotel Marne la Vallée Noisy le Grand, Paris, France with a theme “Accelerating Next Generation Vaccines for Global Health” and was a great success where eminent keynote speakers from various reputed companies and Universities made their resplendent presence and addressed the gathering.  

Euro Vaccines 2017 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Vaccines and Therapeutics.

The highlights of the meeting were the peerless Keynote lectures from:

Shan Lu, University of Massachusetts Medical School, USA

Igor S Lukashevich, University of Louisville, USA

Kei Amemiya, US Army Medical Research Institute of Infectious Diseases, USA

Pascal Breton, VitamFero, France

Ger T Rijkers, University College Roosevelt, Netherlands

Special thanks to our Honorable Moderator, Dr. Randa Hamadeh, Ministry of Public Health, Lebanon for his remarkable contribution towards smooth functioning at Euro Vaccines 2017 Conference.

Conferenceseries Ltd on behalf of the conference congratulates the Best Poster and Young Researchers Forum awardees for their outstanding performance and appreciates all the participants who put their efforts in presentations and sincerely wishes them success in future endeavours.

Conferenceseries Ltd would like to convey a warm gratitude to Chairs and Co-chairs who contributed effervescently for the smooth functioning of the event, Peter Johannes Holst, University of Copenhagen, Denmark, Brian Abel, A*STAR, Singapore, Ger T Rijkers, University College Roosevelt, Netherlands and Pascal Breton, VitamFero, France.
 
Euro Vaccines 2017 conference was a great success with the support of International multi professional steering committee and coordinated by Journal of Vaccines & Vaccination, Journal of Clinical & Cellular Immunology and Immunome Research.

Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Euro Vaccines 2017 conference, and with the enormous feedback from the participants and supporters of  Euro Vaccines 2017, Conferenceseries Ltd is glad to announce 30th Euro Global Summit and Expo on Vaccines & Vaccination June 14-16, 2018 Barcelona, Spain.

Let us meet again @ Euro Vaccines 2018


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date June 14-16, 2018

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Supported By

Journal of Vaccines & Vaccination Journal of Clinical & Cellular Immunology Immunome Research

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by